Palatin Technologies, Inc.

AMEX:PTN

Biotechnology

Healthcare
$9.09 -0.82%

-$0.10 today

Market cap
$236.39M
Beta
0.94
P/E (TTM)
-1.9
EPS (TTM)
-$6.43
52W Low $5.00High $31.00

Volume 0.02M

Average 1.78M

PTN Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Palatin Technologies, Inc.AMEX: PTN

Depreciation & Amortization · Q3 FY2026 · quarter ended Mar 2026

Depreciation & amortization declines year over year

Q3 FY2026 depreciation & amortization of $16.95K fell 68.2% year over year, ahead of the -73.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 17.8% from the prior quarter. Over 3 fiscal years it compounded at -18.9% a year.

Context

  • Depreciation & amortization increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -68.2% holds above the trailing-twelve-month pace of -73.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$16.95K+17.8% QoQ
Last fiscal yearJun 2025
$258.92K-23.6% YoY
LTMMar 2026
$98.72K-73.7% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-68.2%——
1 year-23.6%——
3-year CAGR-18.9%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
258.92K USD
Year-over-year change
-23.6%
4-year CAGR
+50.0%

Depreciation & Amortization vs competitors

How PTN compares with its peers on the latest reported figures

  • PTN's LTM Mar 2026 depreciation & amortization of $98.72K is the lowest of the 2 companies compared; the peer median is $362K.
  • Its year-over-year change of -73.7% is the lowest of 2, against a peer median of -25.1%.
  • Depreciation & amortization amounts to 0.8% of revenue for PTN, versus a peer median of 0.7%.
PTN Competitors Peer median
Depreciation & Amortization for PTN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTTBQ32 Bio Inc.LTM Mar 2026$362K -25.1%+1.9%0.7%
PTNPalatin Technologies, Inc.LTM Mar 2026$98.72K -73.7%-18.9%0.8%
Peer median (excluding PTN) $362K-25.1%+1.9%0.7%

Competitors are the stored peer set for PTN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue(188.6K)1.47M4.85M4.49M0
Cost of Revenue147.84K217.53K418.47K97.64K0
Gross Profit(336.44K)1.25M4.44M4.39M0
Gross Margin178.4%85.2%91.4%97.8%—
Research & Development12.93M21.33M22.63M22.4M14.9M
Selling, General & Admin17.34M16.51M15.29M12.27M7.81M
Operating Expenses33.05M37.84M36.89M26.89M17.46M
Depreciation & Amortization51.12K486.02K288.33K339.08K258.92K
EBITDA(33.52M)(35.68M)(28.4M)(29.38M)(17.03M)
EBITDA Margin17774.4%-2429.9%-585.2%-654.3%—
Operating Income(33.38M)(36.59M)(32.46M)(22.5M)(17.46M)
Operating Margin17701.3%-2491.6%-668.7%-501.0%—
Interest Income23.57K0000
Interest Expense029.68K20.01K17.11K15.03K
Other Income / Expenses(212.39K)390.15K3.75M(7.24M)152.59K
Income Before Tax(33.6M)(36.2M)(28.71M)(29.74M)(17.31M)
Pre-Tax Margin17813.9%-2465.1%-591.5%-662.3%—
Income Tax Expense00(4.67M)00
Net Income(33.57M)(36.2M)(24.04M)(29.74M)(17.31M)
Net Margin17799.2%-2465.1%-495.2%-662.3%—
EPS (Basic)(3.55)(3.79)(2.21)(2.02)(32.15)
EPS (Diluted)(3.55)(3.79)(2.21)(2.02)(32.15)
Weighted Avg Shares9.47M9.54M10.89M14.7M538.35K
Weighted Avg Shares (Diluted)9.47M9.54M10.89M14.7M538.35K

Palatin Technologies, Inc.

AMEX:PTN

Intrinsic Alpha fair value

Locked

Current Price

$9.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.